Exoskeleton Partial‐Coated Stem Cells for Infarcted Myocardium Restoring
- 22 November 2023
- journal article
- research article
- Published by Wiley in Advanced Materials
- Vol. 35 (52) , e2307169
Abstract
The integration of abiotic materials with live cells has emerged as an exciting strategy for the control of cellular functions. Exoskeletons consisting ofmetal–organic frameworks are generated to produce partial‐coated bone marrow stem cells (BMSCs) to overcome low cell survival leading to disappointing effects for cell‐based cardiac therapy. Partially coated exoskeletons can promote the survival of suspended BMSCs by integrating the support of exoskeletons and unimpaired cellular properties. In addition, partial exoskeletons exhibit protective effects against detrimental environmental conditions, including reactive oxygen species, pH changes, and osmotic pressure. The partial‐coated cells exhibit increased intercellular adhesion forces to aggregate and adhere, promoting cell survival and preventing cell escape during cell therapy. The exoskeletons interact with cell surface receptors integrin α5β1, leading to augmented biological functions with profitable gene expression alteration, such as Vegfa, Cxcl12, and Adm. The partial‐coated BMSCs display enhanced cell retention in infarcted myocardium through non‐invasive intravenous injections. The repair of myocardial infarction has been achieved with improved cardiac function, myocardial angiogenesis, proliferation, and inhibition of cell apoptosis. This discovery advances the elucidation of potential molecular and cellular mechanisms for cell‐exoskeleton interactions and benefits the rational design and manufacture of next‐generation nanobiohybrids.Keywords
Funding Information
- National Natural Science Foundation of China (82122014, 82071085, 82020108011)
- National Key Research and Development Program of China (2018YFA0703000)
- Natural Science Foundation of Zhejiang Province (LR21H140001, LQ22C100003, LY22H060007)
This publication has 122 references indexed in Scilit:
- c-Myc Is a Universal Amplifier of Expressed Genes in Lymphocytes and Embryonic Stem CellsCell, 2012
- Myocardial edema: A translational viewJournal of Molecular and Cellular Cardiology, 2012
- Crystal structure of α5β1 integrin ectodomain: Atomic details of the fibronectin receptorJournal of Cell Biology, 2012
- Enhancing cell therapies from the outside in: Cell surface engineering using synthetic nanomaterialsNano Today, 2011
- Hydrogels for Cardiac Tissue EngineeringPolymers, 2011
- Stem Cells for Cardiac Repair: Status, Mechanisms, and New StrategiesStem Cells International, 2011
- Noninvasive Quantification and Optimization of Acute Cell Retention by In Vivo Positron Emission Tomography After Intramyocardial Cardiac-Derived Stem Cell DeliveryJACC, 2009
- Physiology of Cell Volume Regulation in VertebratesPhysiological Reviews, 2009
- Systems approaches to preventing transplanted cell death in cardiac repairJournal of Molecular and Cellular Cardiology, 2008
- Stromal Cell–Derived Factor-1α Is Cardioprotective After Myocardial InfarctionCirculation, 2008